Protagonist Therapeutics, IncPTGX

Market cap

$5.4B

P/E ratio

	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	21	106	82	33	117	124	126	187	97
Marketable securities	57	38	93	100	189	203	112	155	322
Receivable from collaboration partner	-	-	-	-	-	-	-	10	165
Prepaid expenses and other current assets	3	4	3	6	6	9	6	4	8
Total current assets	83	151	138	145	316	341	243	356	592
Marketable Securities, Noncurrent	10	11	-	-	2	-	-	-	140
Property and equipment, net	1	1	1	2	1	2	2	1	3
Restricted Cash, Noncurrent	-	0	0	0	0	0	0	0	0
Operating lease right-of-use asset	-	-	-	6	5	5	3	1	9
Total assets	94	164	139	155	324	348	248	358	745
Accounts payable	1	1	6	3	3	2	4	1	2
Payable to collaboration partner	-	-	8	18	14	2	-	0	-
Accrued expenses and other payables	5	10	11	12	18	38	25	19	24
Deferred revenue	-	-	-	-	-	-	-	-	19
Income taxes payable	-	-	-	-	-	-	-	-	3
Operating lease liability	-	-	-	1	1	2	3	1	1
Total current liabilities	6	43	26	35	40	44	31	21	47
Deferred Revenue, Noncurrent	-	-	-	-	-	-	-	-	12
Operating lease liability - noncurrent	-	-	-	6	5	4	1	-	10
Total liabilities	6	43	27	75	45	48	32	21	69
Common Stock, Value, Issued	-	-	-	-	-	-	-	0	0
Additional paid-in capital	152	222	253	298	563	710	753	952	1,016
Accumulated other comprehensive loss	-0	-0	-0	-0	0	-0	-0	-0	-0
Accumulated deficit	-65	-102	-140	-218	-284	-409	-537	-616	-340
Total stockholders' equity	88	121	113	80	280	300	216	337	675
Total liabilities and stockholders' equity	94	164	139	155	324	348	248	358	745